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Metabolomics profiling reveals new 
aspects of dolichol biosynthesis 
in Plasmodium falciparum
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the cis‑polyisoprenoid lipids namely polyprenols, dolichols and their derivatives are linear polymers of 
several isoprene units. In eukaryotes, polyprenols and dolichols are synthesized as a mixture of four or 
more homologues of different length with one or two predominant species with sizes varying among 
organisms. Interestingly, co‑occurrence of polyprenols and dolichols, i.e. detection of a dolichol along 
with significant levels of its precursor polyprenol, are unusual in eukaryotic cells. Our metabolomics 
studies revealed that cis‑polyisoprenoids are more diverse in the malaria parasite Plasmodium 
falciparum than previously postulated as we uncovered active de novo biosynthesis and substantial 
levels of accumulation of polyprenols and dolichols of 15 to 19 isoprene units. A distinctive polyprenol 
and dolichol profile both within the intraerythrocytic asexual cycle and between asexual and 
gametocyte stages was observed suggesting that cis-polyisoprenoid biosynthesis changes throughout 
parasite’s development. Moreover, we confirmed the presence of an active cis-prenyltransferase 
(PfCPT) and that dolichol biosynthesis occurs via reduction of the polyprenol to dolichol by an active 
polyprenol reductase (PfPPRD) in the malaria parasite.
Malaria is caused by protozoan parasites of the genus Plasmodium and most cases of life-threatening malaria 
are attributable to infection with Plasmodium falciparum. The parasite has a complex life cycle that involves 
the human host and its vector, the Anopheles mosquitoes. All clinical features are caused during the asexual 
intraerythrocytic life cycle due to the repeated invasion of human red blood cells (RBCs). The asexual intraeryth-
rocytic developmental cycle of P. falciparum lasts around 48 h, during which the parasite progresses through four 
morphologically different stages: ring, trophozoite, and schizont stages, ending with rupture of the erythrocyte 
and release of merozoites that will invade new erythrocytes. Transmission of the malaria parasite requires devel-
opment of male and female gametocytes (gametocytogenesis), which are ingested by female mosquitoes during a 
blood meal and undergo sexual reproduction in the mosquito’s midgut. Nondividing P. falciparum gametocytes 
take between 10 and 12 days to fully mature and progress through five morphologically distinct forms (stages I 
to V), which are different from other Plasmodium species.
During their complex life cycle malaria parasites encounter different nutritional environments within and 
between hosts. The presence of de novo and salvage pathways gives parasites a great metabolic flexibility to cope 
with those  changes1,2. For example, mature RBCs are capable of only a few metabolic functions since transcription 
and translation is not present in these cells. However, a wide variety of metabolites are available to the parasite 
in the human  plasma3. Among the metabolic pathways that become inactive in mature RBCs is the mevalonate 
pathway which synthesizes the isoprenoid building blocks isopentenyl diphosphate (IPP) and dimethylallyl 
diphosphate (DMAPP)4. Downstream de novo cis-polyisoprenoid biosynthesis of dolichols is also inactive in 
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mature  RBCs5 but dolichols synthesized during erythropoiesis are still present in  erythrocytes6,7. On the other 
hand, P. falciparum has active isoprenoid biosynthesis during the asexual intraerythrocytic developmental cycle 
as well as during gametocytogenesis where the isoprenoid precursors IPP and DMAPP are synthesized through 
the methylerythritol phosphate (MEP)  pathway8–10.
The MEP pathway is localized in the  apicoplast11,12, a unique chloroplast-like organelle essential for growth 
and pathogenesis of the malaria  parasite13 (Fig. 1). Moreover, supply of the isoprenoid precursor IPP is the sole 
metabolic function of the apicoplast in asexual intraerythrocytic cycle and gametocyte  stages10,14. The fact that 
exogenous supply of IPP alone allows parasites lacking the apicoplast to normally grow and develop indicates 
that IPP is transported out of the apicoplast where the synthesis of cis-polyisoprenoid products is predicted to 
occur (Fig. 1)10,14. cis-Polyisoprenoids (polyprenols, dolichols and their phosphate esters and carboxylic acid 
derivatives) are linear polymers of several isoprene units. These lipids are present in all membrane  systems15,16 
but their biological functions besides protein glycosylation in the ER remains largely unknown. Recently, cis-
polyisoprenoids gained special attention due to several breakthroughs in the field including improvements in 
the analytical techniques for their  analysis17,18, partial identification of their enzymatic  machinery19, and the 
discovery of new biological functions beyond  glycosylation20,21. Among some of these biological functions are 
the regulation of the membrane  fluidity21,22, stimulation of spore wall formation in  yeast20, and scavenging free 
radicals in cell  membranes23–25. Interestingly, in cancer  cells26 and P. falciparum27, protein dolichylation occurs 
as a post-translational event, but functions of such derivatives and enzymes involved in this posttranslational 
protein lipid modification remain unknown.
cis-Polyisoprenoid metabolism and its biological functions in P. falciparum remain poorly understood. The 
initial step of cis-polyisoprenoid de novo biosynthesis in the malaria parasite is common to all isoprenoid 
products (Fig. 1) where a multifunctional enzyme synthesizes farnesyl diphosphate (FPP) and geranylgeranyl 
diphosphate (GGPP)28. Synthesis of cis-polyprenyl diphosphate (PDP) is then proposed to be catalyzed by a 
cis-prenyltransferase (CPT) which adds several IPP molecules in cis-configuration to FPP or GGPP. This step 
is called elongation and in animals occurs in the endoplasmic reticulum (ER) where its downstream products 
dolichyl phosphates (Dol-Ps) serve as lipid oligosaccharide carrier for protein N-glycosylation, C- and O-man-
nosylation and glycosylphosphatidylinositol (GPI) synthesis (reviewed  in29). In other organisms, cis-polyiso-
prenoid synthesis also occurs in peroxisomes  (rat30,  yeast31), lipid droplets  (yeast20,32) and chloroplasts (plants, 
 cyanobacteria21,33). The postulated final steps of cis-polyisoprenoid biosynthesis involve dephosphorylation of 
PDP to polyprenol followed by reduction of the α-isoprene unit by polyprenol reductase (PPRD), also called 
SRD5A3 or DFG10 in mammals and yeast, respectively (Fig. 1). Whether dephosphorylation of PDP is catalyzed 
by one or two  enzymes34 has not been elucidated in any organism. Moreover, it has also been suggested that an 
isopentenol or isopentanol, instead of IPP, is added at the last step, which would avoid the need of dephospho-
rylation or dephosphorylation and reduction, respectively, but it remains to be  addressed15,35.
In eukaryotes, polyprenols and dolichols are synthesized as a mixture of four or more different lengths indi-
cated by the total number of carbons or IPP units, e.g. polyprenol/dolichol 11 or C55, with one or two predomi-
nant species (isoprenologues) where the size varies among organisms. Interestingly, co-occurrence of polyprenols 
and dolichols, i.e. detection of a dolichol along with significant levels of its precursor polyprenol, are unusual in 
eukaryotic cells. In the malaria parasite, cis-polyisoprenoid biosynthesis has received little attention because the 
relevance of glycosylation in Plasmodium was unclear until  recently29, and a previous report established that the 
malaria parasite synthesizes dolichols of 11 and 12 isoprene  units36. However, our untargeted lipidomic analyses 
using liquid chromatography combined with high-resolution mass spectrometry (LC-HRMS) system revealed 
an unusual co-occurrence of polyprenols and dolichols. These results steered us to reexamine cis-polyisoprenoid 
Figure 1.  De novo cis-polyisoprenoid biosynthesis in P. falciparum is predicted to occur in the ER. 
Phosphoenolpyruvate (PEP); pyruvate (PYR); glyceraldehyde 3-phosphate (G3P); 1-deoxy-D-xylulose-5-
phosphate (DOXP); DOXP reductoisomerase (DXR); fosmidomycin (FOS); 2-C-methyl-D-erythritol-4-
phosphate (MEP); hydroxy-3-methyl-but-2-enyl diphosphate (HMBPP); dimethylallyl diphosphate (DMAPP); 
isopentenyl diphosphate (IPP); geranyl diphosphate (GPP); farnesyl diphosphate (FPP); farnesyl-geranylgeranyl 
diphosphate synthase (FGDPS); cis-prenyltransferase (CPT); polyprenyl diphosphate (PDP); polyprenyl 
diphosphate phosphatase (PPP); polyprenol reductase (PPRD); dolichol kinase (DK); dolichyl phosphate (Dol-
P). The α-saturated isoprene unit of dolichol is indicated by a red circle. The figure was drawn using CorelDraw 
2018 (https ://www.corel draw.com/en/).
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biosynthesis in P. falciparum using metabolomics and molecular approaches and revealed that cis-polyisoprenoids 
are more prevalent and diverse in the malaria parasite than previously postulated.
Results
Medium‑long polyprenols and dolichols are present in the asexual and sexual intraerythro‑
cytic stages of P. falciparum. Biosynthesis of dolichol composed of 11 and 12 isoprene units in the schi-
zont stage of malaria parasites has been assessed previously using radiolabeled metabolic precursors followed 
by thin layer chromatography (TLC) and high-performance liquid chromatography (HPLC)  analysis36 as well 
as by purifying unlabeled metabolites by HPLC followed by mass spectrometry (MS) analysis of each  fraction37. 
Modulation of dolichol chain length upon a particular physiological condition has been observed earlier. For 
example, shorter isoprenologues are found in actively dividing cells such as cancer cells compared to not actively 
dividing  cells38,39. Thus, we hypothesized that a similar scenario may occur between actively diving asexual stages 
and nondividing gametocyte stages of P. falciparum. To assess this hypothesis, we performed metabolomics 
analysis by LC-HRMS as we described  previously40. In the asexual schizont stage, we detected the presence of 
both polyprenols and dolichols of 15 to 19 isoprene units with isoprenologues 15, 16 and 17 being the predomi-
nant species (Fig. 2a) while in stage IV gametocytes dolichols of 15 to 20 isoprene units were also present, but the 
predominant species were dolichols of 17, 18, 19 isoprene units (Fig. 2b). Under our experimental conditions, 
polyprenols were almost undetectable in gametocytes. As expected, human RBCs contain low levels of dolichols 
of 18 to 20 isoprene units with 19 being the predominant isoprenologue (Fig. 2c). This is the first time that the 
cis-polyisoprenoid profile is determined by LC-HRMS in P. falciparum, and under our experimental conditions, 
dolichols and polyprenols of 11 and 12 isoprene units were not detected probably due to their low abundance. 
To our knowledge, this is also the first time that co-occurrence of polyprenols and dolichols are reported to be 
present in P. falciparum. Interestingly, a distinctive temporal profile of polyprenols and dolichols in the asexual 
intraerythrocytic developmental cycle of P. falciparum was also observed. In schizont stages, dolichol/polyprenol 
ratios were closer to one except for dolichol 15 while ring and trophozoite stages presented considerably higher 
ratios than schizonts (Table 1).
Medium‑long polyprenols and dolichols are synthesized de novo by P. falciparum. In order to 
confirm that the detected polyprenols and dolichols were in fact synthesized by the parasite, de novo biosynthe-
sis was assessed by metabolic labeling using [1-13C]glucose or [3-13C]IPP (Fig. 3a). The specific labeling pattern 
of isoprene units resulting from glucose metabolism via glycolysis and incorporation through the mevalonate 
and MEP pathway are well  established17,18. Because both the mevalonate and dolichol pathway are inactive in 
human  RBCs4, only MEP pathway-specific labeling patterns are observed in P. falciparum infected  RBCs4,8,9.
Highly synchronous infected RBCs in ring stage at 7% parasitemia were first incubated in glucose-free media 
for 2 h and then supplemented for 24 h with [1-13C]glucose (4 g/L) which is known to be metabolized into [1,5-
13C]IPP (Fig. 3a). A similar scheme was used for the metabolic precursor [3-13C]IPP, but in this case cultures 
were treated for 2 h with 10 µM fosmidomycin (FOS), an inhibitor of 1-deoxy-D-xylulose 5-phosphate reductoi-
somerase (DXR)—a key enzyme of the MEP pathway (Fig. 1)8,12, to reduce > 75% the endogenous IPP pool as we 
reported  previously41, therefore, favoring the uptake of exogenous IPP. Then, cultures were supplemented with 
a mixture of [3-13C]IPP and unlabeled IPP (1:1) at 200 µM final concentration in the presence of FOS. It is well 
established that 200 µM of exogenous IPP is necessary to reverse growth inhibition caused by FOS or the absence 
of the  apicoplast10,14,41–43. During optimization of the 13C-biolabeling experimental design, we established that 
parasites required at least 20–24 h of growth in the presence of the 13C-precursor starting at ring stage in order to 
observe 13C-enrichment in polyprenols and dolichols (data not shown). As previously described by Swiezewska 
and  colleagues17,18, 13C-enrichment in polyprenols and dolichols was observed as a Gaussian distribution of iso-
topologues for each of the 13C-precursors (Fig. 3b, Supplementary Fig. S1). The m/z shift toward higher molecular 
mass mirrors the stochastic distribution of the probability of incorporating differentially labeled 13C-IPP into 
13C-polyprenols, and therefore 13C-dolichols, which is determined by the remaining pool of native metabolic 
precursors in the cell that contain a 13C natural abundance of ~ 1% and the number of 13C-atoms incorporated into 
IPP based on the isotopic dilution due to  metabolism17,44. As shown in Fig. 3a, the probability of [1-13C]glucose 
to potentially label each of the carbon atoms C-1 and C-5 of IPP is around 0.5, thus, it is expected that the m/z 
shift of the Gaussian distribution will center around [M + (n)] with n being the number of isoprene units in the 
polyprenol or dolichol detected as the ammonium adduct. In the case of [3-13C]IPP, the m/z shift of the Gaussian 
distribution will center around [M + (1/2 n)] of the ammonium adduct because cultures were supplemented with 
a mixture of [3-13C]IPP and IPP (that contains a 13C natural abundance of ~ 1%) at the 1:1 molar ratio to reach 
the 200 µM final concentration necessary to fully rescue FOS inhibition as previously  reported14. As expected, 
only unlabeled dolichols were detected in uninfected RBCs since there is no active de novo biosynthesis of iso-
prenoids (Fig. 3c, Supplementary Fig. S1). Altogether, these results confirmed that the detected polyprenols and 
dolichols of 15 to 19 isoprene units are exclusively biosynthesized by the malaria parasite.
It has been demonstrated that P. falciparum stage III gametocytes incorporate and metabolize 13C-glucose45. 
In addition, we previously reported that the MEP pathway intermediates are present in late-stage gametocytes 
and that IPP synthesis is essential for normal gametocytogenesis since gametocytes lacking the apicoplast require 
exogenous IPP supplementation until they reach stage  IV10. Surprisingly, 13C-enrichment in dolichols was not 
detected in stage IV gametocytes when [1-13C]glucose was supplemented starting at stage III (Fig. 4). Therefore, 
these results suggest that synthesis of dolichols occurs earlier than stage III during gametocytogenesis and that 
IPP is required for other isoprenoid products than dolichols in gametocyte stages III to  IV10.
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Figure 2.  Distribution of polyprenol and dolichol species present in P. falciparum schizont stage (a), 
gametocyte stage IV (b), and uninfected RBCs (c) were analyzed by LC-HRMS. Values represent means ± s.e.m. 
of three independent biological replicates. The structures of polyprenol (POH) and dolichol (DOH) are 
illustrated where (n) indicates the number of internal cis-isoprene units. The α-isoprene unit of polyprenols 
(unsaturated) and dolichols (saturated) is indicated by a red circle. The figure was drawn using CorelDraw 2018 
(https ://www.corel draw.com/en/).
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P. falciparum polyprenol reductase restored glycosylation of mCPY and reduced polyprenols 
levels in yeast dfg10Δ mutant cells. We hypothesized that presence of polyprenols in P. falciparum 
indicates that dolichol biosynthesis may occur via reduction of the polyprenol to dolichol by an active PfPPRD 
(PF3D7_1455900) (Fig. 1). Therefore, the coding sequence of the putative PfPPRD was optimized for codon 
usage in yeast and its enzymatic function was confirmed by complementation assays in Saccharomyces cerevi-
siae. It was previously reported by Cantagrel and  colleagues46 that human PPRD (SRD5A3) can complement 
the N-glycosylation defects caused by an inactive yeast DFG10, which is the PPRD in this organism for dolichol 
biosynthesis. As mentioned above, their downstream products Dol-P serve as lipid linked oligosaccharide car-
rier for protein glycosylation (Fig. 1). In this work, we used the dfg10Δ mutant cells where the DFG10 gene is 
deleted from the chromosome and displays a lack of N-glycosylation. Mature carboxypeptidase Y (mCPY) has 
four N-glycosylation sites which are all occupied under normal growth conditions in  yeast47 and depend on a 
functional PPRD/DFG10 (Fig. 5a)46. A single band of fully glycosylated mCPY was observed in wild-type (WT) 
cells when mCPY is fully glycosylated while four extra bands were detected in dfg10Δ mutant cells representing 
Table 1.  Dolichol to polyprenol ratios (DOH/POH) at each stage of the P. falciparum asexual intraerythrocytic 
cycle. Ratios were calculated using the area of the signal corresponding to each metabolite normalized to 
the cell number. Values represent the mean ± s.e.m. from three independent biological replicates. POH-ND, 
polyprenol not detected under the experimental conditions used in this study.
P. falciparum intraerythrocytic stage DOH/POH-15 DOH/POH-16 DOH/POH-17 DOH/POH-18 DOH/POH-19
Ring 7.4 ± 2.0 9.6 ± 3.1 9.2 ± 3.8 POH-ND POH-ND
Trophozoite 30.4 ± 6.7 36.3 ± 6.1 25.6 ± 4.8 23.0 ± 3.5 POH-ND
Schizont 2.1 ± 0.2 0.9 ± 0.1 0.9 ± 0.2 1.1 ± 0.3 0.9 ± 0.2
Figure 3.  De novo biosynthesis of medium-long polyprenols (POH) and dolichols (DOH) in P. falciparum. 
(a) Scheme used for metabolic labeling with [1-13C]glucose or [3-13C]IPP in highly synchronous ring stage 
cultures. Parasites were recovered at schizont stage for LC-HRMS analysis. A representative Giemsa-stained 
smear is shown and scale bar indicates 2 µm. The fate of 13C through the MEP pathway for [1-13C]glucose is 
showed as a half-black circle to indicate 13C abundance, which is 50% of the initial one. A black triangle depicts 
the localization of the 13C atom in the exogenously supplied [3-13C]IPP. (b) A representative mass spectrum 
of the standards polyprenol 17 (m/z [M + NH4]+ = 1,193.1145), dolichol 17 (m/z [M + NH4]+ = 1,195.1208) and 
metabolites detected in P. falciparum schizont stage is shown in the two upper rows. Distribution of the 13C 
isotopologues observed for native polyisoprenoid alcohols due to the natural abundance of 13C is indicated by 
brackets. Metabolically labeled polyprenol and dolichol are shown in the two lower panels and brackets indicate 
the m/z shift observed as a Gaussian distribution of 13C-enriched polyprenol and dolichol isotopologues. (c) 
Mass spectra of dolichol 18 (m/z [M + NH4]+ = 1,263.1868) from uninfected human RBCs cultured in the 
absence or presence of [1-13C]glucose under the same conditions as P. falciparum showing lack of de novo 
dolichol biosynthesis. Data presented are representative of three independent biological replicates. The figure 
was generated using CorelDraw 2018 (https ://www.corel draw.com/en/) and Adobe Photoshop 21.2.0 (https ://
www.adobe .com/produ cts/photo shop.html).
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the different glycoforms (− 1, − 2, − 3, − 4) (Fig. 5a, lane 2). The mutant transformed with yeast DGF10 or PfPPRD 
under the control of the endogenous DFG10 promoter showed full correction of the CPY underglycosylation. 
Some underglycosylated CPY was still detected in cells expressing PfPPRD, suggesting that this enzyme was not 
as active as the yeast DFG10.
In order to confirm the biochemical effects underlying the yeast complementation, we assessed the profile 
of polyprenols and dolichols by LC-HRMS (Fig. 5b). As described  previously5,46, only dolichol 15 and 16 were 
detected in WT yeast while polyprenols along with dolichols were detected in the dfg10Δ mutant cells. As 
expected, dfg10Δ mutant cells expressing PfPPRD showed reduction of the polyprenol levels confirming its 
predicted enzymatic function (polyprenol → dolichol).
Modification of the CPT and PPRD locus in P. falciparum. Two recent functional profiling studies 
of the Plasmodium genome indicate that Plasmodium PPRD (PF3D7_1455900) and CPT (PF3D7_0826400) are 
predicted to be  essential48,49. Thus, in order to gain insight into the polyprenol and dolichol biosynthesis in P. 
falciparum, we used the CRISPR/Cas9 with the tetracycline repressor (TetR) and development of zygote inhib-
ited (DOZI) fusion protein to generate a TetR-DOZI inducible knockdown (KD) mutant  strain50 of PfCPT or 
PfPPRD (Fig. 6a). We successfully modified the PfPPRD genomic locus of 3D7 strain (Fig. 6b). We attempted 
to generate a C-terminus triple-human influenza hemagglutinin (HA) tagged PfPPRD to assess its localization 
Figure 4.  Representative mass spectrum of dolichol 17 (DOH-17) (m/z [M + NH4]+ = 1,195.1208) detected in 
P. falciparum gametocyte cultures metabolically labeled with [1-13C]glucose starting at stage III and recovered 
at stage IV for LC-HRMS analyses as indicated in the scheme. 13C-Enrichment was not detected in dolichols 
from gametocytes under the described experimental conditions. Scale bar indicates 3 µm. Data presented are 
representative of three independent biological replicates. The figure was generated using CorelDraw 2018 (https 
://www.corel draw.com/en/) and Adobe Photoshop 21.2.0 (https ://www.adobe .com/produ cts/photo shop.html).
Figure 5.  PfPPRD restored N-glycosylation of mCPY and reduced levels of polyprenols (POH) in yeast dfg10Δ 
mutant cells. (a) Glycosylation status of CPY in dfg10Δ mutant cells expressing yeast DFG10 or PfPPRD. 
Positions of mature CPY (mCPY) and its glycoforms (− 1, − 2, − 3, − 4) are indicated. Empty vector (vector) was 
used as a control. (b) Extracted ion chromatogram (EIC) from LC-HRMS analyses of yeast strains showing that 
for WT only dolichol (DOH) of 15 and 16 isoprene units are detected while in dfg10Δ mutant strain dolichols 
are accompanied by their respective polyprenols 15 and 16. Yeast dfg10Δ mutant strain transformed with 
PfPPRD showed considerable reduction of polyprenols 15 and 16. Data presented are representative of three 
independent biological replicates. The figure was generated using CorelDraw 2018 (https ://www.corel draw.com/
en/) and Adobe Photoshop 21.2.0 (https ://www.adobe .com/produ cts/photo shop.html).
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but multiple attempts with this construct failed (Supplementary Fig. S2) suggesting that PfPPRD tagged at the 
C-terminus is not efficiently translated or the protein is unstable. It is also possible that the highly conserved 
catalytic domain of PfPPRD is located in the C-terminal as predicted for the human and plant  orthologs46,51 and 
tagging interferes with proper enzymatic function. On the other hand, we were able to generate a C-terminus 
triple-HA tagged PfCPT in 3D7 strain (Fig. 6b). Both P. falciparum transgenic strains were subjected to clonal 
selection and genomic modifications were confirmed by DNA sequencing.
Characterization of PfPPRD and PfCPT conditional knockdowns. The untagged conditional KD 
system of PfPPRD (PfPPRD-TetR-DOZI) was induced by removing anhydrotetracycline (aTc), which relieves 
translational repression by the TetR-DOZI  complex50 (Fig. 7a). Interestingly, morphological defects and a slight 
but significant growth defect were observed only after 8  days (5th intraerythrocytic life cycle) without aTc 
(Fig. 7b). We were not able to obtain a PfPPRD-HA-TetR-DOZI strain (Supplementary Fig. S2), thus, it was not 
possible to determine whether the observed growth and morphological defects were attributed to a gradual or 
incomplete reduction in PfPPRD protein levels as this enzyme is predicted to be  essential49. However, the levels 
of polyprenols and dolichols were determined by LC-HRMS to assess whether PfPPRD enzymatic activity was 
reduced in the absence of aTc confirming that PfPPRD synthesizes dolichols in vivo. Metabolomics analyses 
were performed in trophozoite stage parasites where the highest dolichol to polyprenol ratios are observed due 
to low levels of detectable polyprenols (Table 1). In the absence of aTc for 3 days, parasites displayed a pro-
nounced accumulation of polyprenols 15 to 18 and a slight reduction of dolichols 15 to 17 without changes in 
the levels of dolichol of 18 to 20 isoprene units suggesting that some residual PfPPRD activity may still be present 
Figure 6.  Successful generation of a P. falciparum PfPPRD-TetR-DOZI or PfCPT-HA-TetR-DOZI conditional 
knockdown. (a) Schematic representation of plasmids used and integration of the linearized TetR-DOZI 
plasmid with a 10 × aptamer system into PfPPRD and PfCPT genes. The endonuclease cas9 promotes a double-
stranded break in the genomic locus while the repair plasmid provides a homology region at the C-terminus of 
PfPPRD or PfCPT (target-C-t) for double crossover homologous recombination to introduce a 3′-untranslated 
region (UTR) RNA aptamer sequence that binds a tetracycline repressor (TetR) and development of zygote 
inhibited (DOZI) fusion protein to generate the TetR-DOZI conditional system. (b) PCR analysis confirmed 
integration at the recombinant locus. Wild-type parasites were detected using primers P8-P2 for PfPPRD and 
P17-P11 for PfCPT (see Supplementary Table S1) after 4 days of transfection (A’). Conditional knockdown 
parasites were detected after 30 days post-transfection (B’) using primers P8-P9 for PfPPRD and P17-P9 for 
PfCPT. The figure was generated using CorelDraw 2018 (https ://www.corel draw.com/en/) and Adobe Photoshop 
21.2.0 (https ://www.adobe .com/produ cts/photo shop.html).
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(Fig. 7c). Surprisingly, after 10 days of aTc removal a similar pronounced accumulation of polyprenols 15 to 18 
was observed but dolichols 15 to 17 were undetectable while dolichols 18 to 20 were not significantly reduced 
(Fig. 7d).
In order to assess if the detected dolichols of 18 to 20 isoprene units were de novo biosynthesized by parasites, 
we performed metabolic labeling with [1-13C]glucose in cultures after 10 days of aTc removal. 13C-Enrichment 
was observed in polyprenol 18 but not in dolichols 18 to 20 suggesting that the detected dolichols in cultures 
after 10 days of aTc removal were not synthesized de novo by parasites (Fig. 8, Supplementary Fig. S3). Consistent 
with our results shown in Table 1, polyprenol 19 was undetectable in trophozoite stage both with and without 
aTc supplementation. Dolichols of 18 to 20 isoprene units are present in uninfected RBCs (Fig. 2c) and the 
treatment with saponin used to isolate whole infected erythrocytes depleted of hemoglobin does not separate 
the host erythrocyte membrane from the  parasite52 (see “Materials and methods”). Therefore, we cannot rule 
out that the detected dolichols of 18 to 20 isoprene units are those present in the erythrocyte membrane, which 
their detection became more prevalent in the absence of biosynthesis by parasites. Thus, it is possible that the 
Figure 7.  Characterization of PfPPRD conditional knockdown mutant. (a) Schematic representation of the 
PfPPRD conditional knockdown mechanism. The modified PfPPRD locus contains a 3′-UTR RNA aptamer 
sequence that binds to TetR and DOZI fusion protein. In the presence of anhydrotetracycline (aTc), the 
TetR-DOZI complex is stabilized and the 3′-UTR aptamer is unbound. Removal of aTc causes binding of 
the TetR + DOZI repressor to the aptamer region which results in reduced protein levels. (b) Time-course of 
growth of PfPPRD-TetR-DOZI knockdown parasites treated with BSD only (− aTc) or BSD + aTc. Data are 
shown as mean ± SD (two independent experiments performed in triplicate) with error bars smaller than the 
dots. Individual values are shown in Supplementary Table S2. (*) Indicates p < 0.0001. A representative Giemsa-
stained thin smear of parasites cultured in the presence or absence of aTc showing morphological defects 
observed in parasites after 8 days of aTc removal. The distribution of polyprenol (POH) and dolichol (DOH) 
species present in P. falciparum PfPPRD-TetR-DOZI were analyzed by LC-HRMS in trophozoite stage after 
aTc was removed from cultures for (c) 3 days and (d) 10 days. Values are average ± s.e.m. from three biological 
replicates. The figure was generated using CorelDraw 2018 (https ://www.corel draw.com/en/) and Adobe 
Photoshop 21.2.0 (https ://www.adobe .com/produ cts/photo shop.html).
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Figure 8.  13C-Enrichment due to de novo biosynthesis in the PfPPRD mutant strain was observed for polyprenol 18 in 
P. falciparum after 10 days aTc was removed (a) while 13C-enrichment was undetectable for dolichol 18 (b) supporting 
that PfPPRD enzymatic activity is negligible. Metabolic labeling with [1-13C]glucose was performed as indicated in Fig. 3a 
(scheme) and as described in the methodology section. Natural isotopic distribution for polyprenol (POH) and dolichol 
(DOH) is indicated for the standard. 13C-Enrichment from [1-13C]glucose is detected as a Gaussian distribution as indicated 
in the PfPPRD + aTc spectrum. A representative mass spectrum of three independent biological replicates of polyprenol 
18 (m/z [M + NH4]+ = 1,261.1712) and dolichol 18 (m/z [M + NH4]+ = 1,263.1742) is shown. The figure was generated using 
CorelDraw 2018 (https ://www.corel draw.com/en/).
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lack of severe growth defect observed in the PfPPRD mutant is due to polyprenols performing the biological 
functions of dolichols in P. falciparum.
To further investigate if lack of polyprenols may be essential for the malaria asexual intraerythrocytic devel-
opmental cycle, we performed the same analyses using the conditional KD system of PfCPT-HA-TetR-DOZI. 
Parasites maintained in the presence of aTc displayed both normal growth and morphology with active cis-
polyisoprenoid biosynthesis (Fig. 9, Supplementary Fig. S4) supporting that presence of a C-terminal triple 
HA tag does not affect PfCPT function. Removal of aTc for 6 days showed a striking reduction of the levels of 
polyprenols 15 to 18 and dolichols 15 to 19 confirming the enzymatic function of PfCPT in vivo. Recently, PfCPT 
was predicted to be essential in a functional profiling study of the P. falciparum  genome49; however, we did not 
observe a lethal phenotype suggesting that some residual PfCPT activity may still be present in the conditional 
KD allowing parasites to grow normally. Likewise, the hypothesis that an unexpected alternative pathway may be 
present in the malaria parasite cannot not be ruled out with the current data. Interestingly, PfCPT-KD (Fig. 9a) 
phenocopied PfPPRD-KD (Fig. 7d) since dolichols of 18 to 20 isoprene units became the predominant spe-
cies after several days of aTc removal. We also performed principal component analysis (PCA) where results 
are displayed as score plots, and each point represents a sample that when clustered together indicates similar 
metabolite composition based on the metabolomic analysis performed, which in this case was for nonpolar 
lipids including polyisoprenoids present in the hexane fraction. As expected, a significant change in the parasite 
metabolome was observed in the absence of aTc (Fig. 9b). As mentioned above, we confirmed the presence of 
the triple HA tag by DNA sequencing; however, PfCPT-HA could not be detected by western blot, but it was 
detected by immunofluorescence microscopy (IFA) suggesting low expression (Fig. 9d).
Figure 9.  Characterization of PfCPT conditional knockdown mutant. (a) Distribution of polyprenol (POH) 
and dolichol (DOH) species in late trophozoite (LT) and early schizont (ES) stages in control (+ aTc) and PfCPT 
knockdown mutant after 6 days of aTc removal. Values are average ± s.e.m. from three independent biological 
replicates. (b) PCA model score plot of LC-HRMS data from three biological triplicates. (c) Giemsa-stained 
thin smear of parasites recovered for LC-HRMS analyses. (d) Colocalization with anti-BiP (ER, green), anti-HA 
(PfCPT, red), and DAPI (nuclei, blue) in asexual intraerythrocytic stages by IFA. R: ring stage, S: schizont stage. 
Scale bar indicates 2 µm. The figure was generated using CorelDraw 2018 (https ://www.corel draw.com/en/) and 
Adobe Photoshop 21.2.0 (https ://www.adobe .com/produ cts/photo shop.html).
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PfCPT and PfPPRD knockdowns have normal MSP1 localization. One of the main known biologi-
cal functions of dolichols is their role in the synthesis of GPI. The merozoite surface protein 1 (MSP1) is a well-
studied GPI-anchored protein uniformly distributed in the parasite plasma membrane and a highly abundant 
ligand coating the merozoite  surface53. MSP1 plays a role not only during invasion of RBCs but also during para-
site’s egress and it is predicted to be  essential49,53. Previously, using an inducible Cre recombinase-mediated exci-
sion system, it was shown that a truncated MSP1 that lacked a GPI anchor is trafficked to the parasitophorous 
vacuole but is not attached to the merozoite plasma membrane showing a punctuate localization rather than a 
uniform  distribution53. Moreover, these mutants presented a substantially reduced replication  rate53. Because 
both PfPPRD-KD and PfCPT-HA-KD presented an altered polyprenol and dolichol profile without a lethal 
or severe growth defect phenotype, we hypothesized both mutants are able to still carry out protein glycosyla-
tion. Therefore, we assessed the localization of MSP1 in PfPPRD-KD and PfCPT-HA-KD by IFA (Fig. 10). As 
expected, MSP1 showed normal localization as previously  reported53 in the presence of aTc and no differences 
were observed in both mutants compared to controls after 10 days of aTc removal suggesting that posttransla-
tional GPI modifications are not affected. Altogether, our results reported here suggest that either polyprenols 
may substitute dolichols as a lipid-linked sugar donor for glycosylation in P. falciparum explaining the lack of a 
severe growth defect in the PfPPRD mutant strain, or although dolichol production was sharply reduced, suf-
ficient levels remained for normal posttranslational modification and localization of MSP1. Nevertheless, both 
proposed hypotheses guarantee further investigations.
Discussion
Our studies using 13C-profiling by LC-HRMS uncovered for the first time in P. falciparum co-occurrence of 
polyprenols and dolichols as well as synthesis of longer dolichol species than previously reported. The presence 
of a distinctive polyprenol and dolichol profile within the intraerythrocytic asexual cycle and between asexual 
and gametocyte blood stages suggest that cis-polyisoprenoid biosynthesis changes throughout parasite’s devel-
opment. Interestingly, in mammals and plants increased level of polyprenol to dolichol ratio results in aberrant 
glycosylation with shorter  glycans54. However, it is difficult to assess if a similar response occurs in the malaria 
Figure 10.  Colocalization of fluorescence signals of anti-MSP1 antibody (green) and DAPI (nuclei, blue) in late 
schizont stage of PfPPRD or PfCPT mutant strains analyzed by IFA. The aTc supplementation was removed for 
at least 10 days prior to imagining. Scale bar indicates 10 µm. The figure was generated using Adobe Photoshop 
21.2.0 (https ://www.adobe .com/produ cts/photo shop.html).
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parasite since it has been shown that Plasmodium synthesizes very short N-glycans29,55. cis-Polyisoprenoid lipids 
are present in all membrane  systems15,16 but their biological functions besides protein glycosylation in the ER 
remain largely unknown. A recent fluorescence anisotropy analysis performed in the protein-dense thylakoid 
membranes of the chloroplast, revealed that membrane areas with less polyprenols had greater membrane fluid-
ity and photosynthesis was  affected21. These analyses together with numerous in vitro studies employing model 
 membranes5 suggest that polyprenols affect the biophysical characteristics of biological membranes. Moreover, 
it was recently demonstrated in yeast that lipid droplets of vegetative cells contain mainly dolichols of 14 to 17 
isoprene units while sporulating cells not only shift toward longer dolichol species (19 to 24 isoprene units) but 
also accumulate similar levels of polyprenols of 19 to 24 isoprene units. Long-chain polyprenols synthetized by 
a developmentally regulated CPT present in lipid droplets (Srt1) promote spore wall formation by serving as a 
signal that activates chitin synthase (directly or indirectly which remains to be determined) possibly through 
changes in the membrane structure introduced by  polyprenols20. Therefore, it is possible that the changes in the 
size of polyisoprene chain and levels of co-occurrence of polyprenols and dolichols during the intraerythrocytic 
life cycle and gametocyte stages may be associated with their participation in other cellular processes beside 
glycosylation which guarantees further investigation.
The presence of polyprenols in P. falciparum supports that dolichol biosynthesis occurs via reduction of 
the polyprenol to dolichol and we confirmed that this step is catalyzed by PfPPRD (PF3D7_1455900) which is 
predicted to be essential in blood  stages49. Intriguingly, our PfPPRD mutant strain revealed that after aTc has 
been removed for several days, shorter dolichols were undetectable while dolichols of 18 to 19 isoprene units 
were still present but not synthesized de novo. Due to limitations of current tools to study the metabolism of 
cis-polyisoprenoids and their biological functions as well as in the approaches to separate parasites from its 
host erythrocyte membrane, it cannot be ruled out that the detected dolichols of 18 to 20 isoprene units are 
in fact present in the erythrocyte membrane and are not internalized by the parasite. Interestingly, PfPPRD 
knockdown mutant was not lethal but after at least 8 days of aTc removal a slight but significant growth defect 
as well as abnormal parasites were observed. Metabolomics analysis revealed that polyprenols were drastically 
increased in the PfPPRD knockdown mutants. As mentioned above, numerous in vitro studies employing model 
 membranes5 suggest that polyprenols affect the biophysical characteristics of biological membranes. Therefore, 
it is also possible that the high levels of polyprenols detected in the absence of aTc may have affected membranes 
and their functions, thus, contributing to the slight growth and morphological defects observed. In addition, 
it cannot be ruled out that polyprenols may be able to perform some of the functions of dolichols when their 
synthesis is compromised including glycosylation as it has been previously suggested to occur in fibroblasts from 
patients carrying a homozygous SRD5A3 mutation, the human orthologue of  PfPPRD54 as well as in Chinese 
hamster ovary  cells56,57. The efficiency of glycosylation by polyprenols in mammalian cells seems to be lower 
compared to dolichols and detrimental for  cells54. Therefore, it is possible that a similar scenario is occurring 
in the PfPPRD mutants which may also contribute to the slight growth defect observed. However, we did not 
observed differences in the localization of MSP1 in the PfCPT and PfPPRD knockdown strains when com-
pared to controls suggesting that GPI biosynthesis is not affected in these mutants. As mentioned above, MSP1 
lacking a GPI anchor is trafficked to the parasitophorous vacuole but is not attached to the merozoite plasma 
membrane showing a punctuate localization rather than uniform distribution as we observed in our  studies53. 
In the case of the PfPPRD mutant, normal localization of MSP1 suggests that polyprenols may be able to carry 
out glycosylation (Figs. 7,10), if the dolichols of 18 to 19 isoprene units detected in the absence of aTc are local-
ized in the erythrocyte membrane and they are not internalized by the parasite. However, we cannot rule out 
that although dolichol production was sharply reduced, sufficient levels remained for normal posttranslational 
modification and localization of MSP1. On the other hand, normal localization of MSP1 in the PfCPT mutant 
may be explained by the fact that the knockdown system used was unable to completely eliminate polyprenol 
biosynthesis suggesting that parasites can carry out normal glycosylation with low levels of dolichols (Figs. 9,10). 
Currently, we are attempting to generate an inducible knockout of PfCPT to assess its predicted  essentiality49 or 
if an unexpected alternative pathway may be present in the malaria parasite. Nevertheless, further investigations 
are needed to verify that polyprenols can be phosphorylated and glycosylated as dolichols in the malaria parasite.
As a result of several breakthroughs in the field of cis-polyisoprenoids17,19,20, new biological functions of 
these lipids are starting to be unveiled besides their known role in protein glycosylation. Further studies are still 
needed to answer why co-occurrence of polyprenols and dolichols is present in the malaria parasite as well as 
why cis-polyisoprenoid species change during the parasite’s life cycle which may reveal new biological functions 
of these unique lipids.
Materials and methods
Chemicals. The isotopically labeled intermediate [1-13C]glucose (99% isotopic abundance) was obtained 
from Cambridge Isotope Laboratories Inc (Tewksbury, MA, USA). [3-13C]IPP (99% isotopic abundance) from 
Isoprenoids LC (Tampa, FL, USA) was a kind gift from Dr. Dennis Kyle. All chemicals used in the metabolomics 
studies were LC/MS grade and purchased from Millipore-Sigma (Burlington, MA, USA). RPMI 1,640, HEPES, 
gentamycin and Albumax I were obtained from GIBCO Life Technologies (Thermo Fisher Scientific, Waltham, 
MA, USA). Glucose, sodium bicarbonate, hypoxanthine (Millipore-Sigma, Burlington, MA, USA). Polyprenols 
and dolichols mixtures of 13 to 21 isoprene units were obtained from Avanti Polar Lipids (Alabaster, AL, USA). 
Polyprenols of 11 and 12 isoprene units were obtained from Isoprenoids LC (Tampa, FL, USA). Dolichols of 
11 to 14 isoprene units were from the Collection of Polyprenols, Institute of Biochemistry and Biophysics PAS, 
Warsaw, Poland.
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Parasite cultures. Plasmodium falciparum 3D7 and NF54 strains were obtained through the MR4 Malaria 
Reagent Repository (ATCC, Manassas, VA, USA) as part of the BEI Resources Repository, NIAID, NIH. Para-
sites were maintained at 5% hematocrit in  O+ human erythrocytes (The Interstate Companies, TN, USA) in 
RPMI 1,640 supplemented with 5 g/L Albumax I, 2 g/L glucose, 2.3 g/L sodium bicarbonate, 370 µM hypox-
anthine, 25 mM HEPES, and 20 mg/L gentamycin. Cultures were maintained at 37 °C under reduced oxygen 
conditions (5%  CO2, 5%  O2, and 90%  N2).
Stable isotope labeling of P. falciparum‑infected and uninfected RBCs for polyisoprenoids 
profiling. Mycoplasma-free parasite cultures were tightly synchronized by two consecutive treatments with 
5% sorbitol (Millipore-Sigma, Burlington, MA, USA). Each biological replicate was obtained from 75 mL of 
P. falciparum-infected RBC cultures at 5% hematocrit and 7% parasitemia. For stage-specific polyisoprenoid 
profiling, parasites in trophozoite and schizont stages were obtained from P. falciparum-infected RBC cultures 
starting with early ring stage at 7% parasitemia and harvesting parasites at each indicated stage. Parasites at ring 
stage were obtained from synchronized cultures starting with early rings of P. falciparum at 3% parasitemia and 
recovering parasites after 48 h incubation to avoid collecting cells after sorbitol treatment.
For metabolic labeling experiments using [1-13C]glucose, cultures in ring stage (5% hematocrit and 7% para-
sitemia) were first incubated in glucose-free RPMI 1,640 for 2 h and then supplemented with 4 g/L of [1-13C]
glucose for 22–24 h. RPMI 1,640 without glucose was prepared as we described  previously40. For metabolic 
labeling experiments using [3-13C]IPP, cultures in ring stage were first treated with 10 µM fosmidomycin for 2 h 
and then supplemented with [3-13C]IPP:IPP (1:1, 200 µM) in the presence of fosmidomycin. In all cases, each 
biological replicate obtained for infected RBCs was accompanied by its corresponding uninfected human RBCs 
cultures as controls.
In order to assess dolichol and polyprenol profiles in trophozoite stage of the PfPPRD or PfCPT conditional 
knockdowns, parasites were grown in media supplemented either with 2.5 µg/mL Blasticidin S and 0.5 µM aTc, 
or only 2.5 µg/mL Blasticidin S for the indicated times (Figs. 7,9). 13C-Biolabeling experiments were performed 
under similar conditions to induce the knockdowns and then metabolically labeled as described above.
In all cases, infected RBCs were treated with 0.03% saponin in cold phosphate-buffered saline (PBS) solu-
tion containing 2 g/L glucose and washed three times with PBS/glucose by centrifuging 7 min at 10,000 × g at 
4 °C. Ten µL were collected in the last wash to count parasites using a Countess cell counter (Thermo Fisher 
Scientific, Waltham, MA, USA). Cell pellets were flash-frozen and stored at − 80 °C until metabolite extractions 
were performed.
Gametocyte stages were obtained using P. falciparum NF54 strain grown in human pooled serum (Interstate 
Blood Bank, TN, USA) to a final concentration of 10%. Briefly, highly synchronous cultures at early ring stage 
were obtained by sorbitol treatment, purified using a  MACS® magnetic affinity column (day 0) and set at 8–12% 
parasitemia and 5% hematocrit. On day 0 and 1, gametocytogenesis was induced by incubating cultures with 
50% spent media and 50% fresh media for 40–48 h, as described  previously58. After reinvasion, asexual parasites 
were depleted from culture by addition of fresh media containing 20 U/mL of heparin for 4 days (day 2 to 5) 
and sorbitol  treatment59. After day 5, the media was replaced every two days until gametocytes reached stage 
IV. Development of parasites was monitored by microscopic evaluation of Giemsa-stained thin smears. For 
metabolic labeling experiments, stage III gametocyte cultures where obtained as described above (day 6 after 
induction). Then, parasites were incubated in glucose-free media for 2 h before adding [1-13C]glucose (4 g/L) 
and incubated for 24 h when media was changed to add fresh [1-13C]glucose (4 g/L) and to complete a total of 
48 h labeling until gametocytes reached stage IV.
Sample preparation and polyisoprenoid profiling by LC‑HRMS. Extraction of metabolites and LC-
HRMS analysis was performed as we previously  described40. Briefly, 1 mL cold methanol was added to each sam-
ple and three consecutive extractions with 2 mL of hexane followed by pulse-vortex for 1 min and 10 min sonica-
tion in an ultrasonic bath. The upper phases were combined, dried under nitrogen and stored at − 80 °C until 
LC-HRMS analysis. For LC-HRMS analysis, samples were resuspended in 100 µL of methanol/acetonitrile/2-
propanol (60:25:15, v/v) pulse vortex 5 times and sonicate for 10 min. Analysis of polyisoprenoids was per-
formed on an ionKey/MS system composed of an ACQUITY UPLC M-Class, the ionKey source, and an iKey 
HSS T3, 100 Å, 1.8 μm (particle size), 150 μm × 100 mm column coupled to a SYNAPT G2-Si mass spectrometer 
(Waters Corporation, Milford, MA, USA). Isoprenoid separation was accomplished as described  previously40 
and a representative extracted ion chromatogram is shown in Supplementary Fig. S5. For unlabeled samples, 
peak identification, alignment, normalization, and statistical treatment of the data was performed using Progen-
esis QI software (Nonlinear Dynamics, Waters Corporation, Milford, MA, USA). For 13C-biolabeled samples, 
MassLynx software (Waters Corporation, Milford, MA, USA) was used for data processing and 13C-labeling dis-
tribution analysis. The area of the analyte (metabolite) peak was normalized to the cell number and the response 
of each detected metabolite is expressed as the mean and s.e.m. of at least three independent biological replicates.
Heterologous expression of PfPPRD and analysis of CPY glycosylation in Saccharomyces 
cerevisiae transformants. HA-tagged DFG10 and PfPPRD (optimized for codon usage in yeast) were 
expressed under the control of the DFG10 endogenous promoter from a centromeric plasmid, pRS416. Empty 
vector pRS416 was included as a negative control. Saccharomyces cerevisiae strain BY4741 (MATa his3Δ1 leu2Δ 
met15Δ ura3Δ) and BY4741-based dfg10Δ strains were grown at 30  °C in synthetic complete (SC) medium 
containing 2% galactose as the carbon  source60. Uracil was omitted from the medium to maintain the plasmid. 
After two passages (36 to 48 h) in SC medium, cells were harvested when the optical density at 600 nm  (OD600) 
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reached between 0.4 and 1.0. Two  OD600 units of cells were harvest for protein analysis and 25  OD600 units of cells 
were harvested for analysis of polyisoprenoids by LC-HRMS.
Total proteins were extracted as described  previously61. Equal amount of proteins was analyzed using a 12% 
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and transferred to a polyvinylidene 
difluoride (PVDF) membrane. Mouse anti-CPY (1:5,000; Life Technologies, Thermo Fisher Scientific, Waltham, 
MA, USA) was used as the primary antibody; horseradish peroxidase (HRP)-conjugated anti-mouse antibody 
(1:5,000 dilution; Thermo Fisher Scientific, Waltham, MA, USA) together with the Supersignal West Femto 
substrate (Thermo Fisher Scientific, Waltham, MA, USA) were used to detect the target protein.
Generation of a P. falciparum strain with an inducible knockdown of PfPPRD or PfCPT. Genomic 
DNA was isolated from P. falciparum 3D7 strain and homology regions were PCR amplified using PrimeStar 
GXL DNA polymerase (Takara Bio Inc., Mountain View, CA, USA). The 3′-untranslated homology region (3′-
UTR) was amplified using forward P1 and reverse P2 primers (Supplementary Table S1). The C-terminal homol-
ogy region was amplified using forward primer P3 and reverse primer with triple-hemagglutinin (HA) tag P4 or 
without HA tag P5. The 3′-UTR and C-terminal homology regions were combined using forward P1, reverse P4 
or P5 primers and PrimeStar GXL DNA polymerase (Takara Bio Inc., Mountain View, CA, USA). The resulted 
PCR product was cloned into TetR-DOZI  plasmid50 by sequence- and ligation-independent cloning (SLIC) 
using T4 DNA polymerase (Thermo Fisher Scientific, Waltham, MA, USA) as previously  described62. Before 
transfection, PfPPRD-HA-TetR-DOZI and PfPPRD-TetR-DOZI plasmids were linearized with EcoRV (New 
England BioLabs, Ipswich, MA, USA). The RNA guide (gRNA) sequence was chosen using ChopChop online 
platform (https ://chopc hop.cbu.uib.no/). Primers forward P6 and reverse P7 were annealed and inserted into 
pUF1-Cas9-guide63 as previously  described64. Briefly, pUF1-Cas9-guide was digested with BtgZI and annealed 
oligos were inserted using the SLIC method.
The same approach described above was used to generate a conditional knockdown of PfCPT. Briefly, the 
3′-UTR region was amplified using primers forward P10 and reverse P11. The C-terminal homology region was 
amplified using primers forward P12 and reverse with or without HA tag P13 and P14, respectively. After com-
bination of the homology regions, SLIC and cloning, PfCPT-HA-TetR-DOZI and PfCPT-TetR-DOZI products 
were linearized for transfection using HPaI (New England BioLabs, Ipswich, MA, USA). Primers forward P15 
and reverse P16 were used for annealing and insertion of the guide RNA into pUF1 vector previously digested.
Twenty µg of each linearized plasmid was mixed with 60 µg of pUF1-Cas9-guide and precipitated. DNA pel-
let was dissolved in Cytomix  Buffer50 and combined with fresh red blood cells (RBCs). The DNA/RBC mixture 
was electroporated using BioRad Gene Pulser Xcell system at 0.32 kV and 925 µF. A culture of P. falciparum in 
schizont stage at 10–15% parasitemia was added to the RBCs and parasites were grown in the presence of 0.5 µM 
aTc (Cayman Chemical, Ann Arbor, MI, USA). Drug pressure was applied 48 h post-transfection using 2.5 µg/
mL Blasticidin S (BSD) (Millipore-Sigma, Burlington, MA, USA). Media was changed daily for the first 7 days 
and every other day thereafter. P. falciparum cultures were split 1:1 every 7 days to provide fresh uninfected RBCs 
and to perform DNA extraction for integration analysis.
Growth and morphological assessment of the PfPPRD‑TetR‑DOZI and PfCPT‑HA‑TetR‑DOZI. 
In order to assess potential morphological defects due to the reduced expression of PfPPRD and PfCPT, P. 
falciparum cultures treated with BSD only or BSD + aTc as indicated above were monitored by Giemsa-stained 
smears every 24 h for over 8 days. Potential growth defects were assessed by seeding cultures in a 96 well plate 
(0.5% early trophozoite stages at 4% hematocrit) and treated with BSD only (− aTc) or BSD + aTc with each 
condition tested in triplicate. Throughout the course of the experiment, parasites were sub-cultured to maintain 
the parasitemia between 1 and 5%. Parasitemia was monitored every 24 h by flow cytometry using a CytoFLEX 
S (Beckman Coulter, Hialeah, FL, USA). A sample of 0.5 µL from each well was stained with Hoechst (Thermo 
Fisher Scientific, Waltham, MA, USA) at 0.8 µg/mL in PBS and data were analyzed using Prism (GraphPad Soft-
ware, Inc.). Relative parasitemia at each time point was back calculated based on actual parasitemia multiplied 
by the relevant dilution factors.
Statistical analysis. The t-test and Benjamini and Hochberg procedure were used to analyze differences 
between different conditions, and a false discovery rate of 0.01 was used to identify statistically significant dif-
ferences.
Fluorescence microscopy. Cells were fixed using a mixture of 4% paraformaldehyde and 0.015% glutar-
aldehyde and permeabilized with 0.1% Triton-X100 as described  previously62. Primary antibodies used for IFAs 
in this study were the following: mouse anti-MSP1 antibody (European Malaria Reagent Repository, 1:500), rat 
anti-PfBiP MRA-1247 (BEI Resources, NIAID, NIH, 1:100) and mouse anti‐HA(6E2) (Cell Signaling Technol-
ogy Inc., 1:100). Anti-mouse and anti-rat antibody conjugated to Alexa Fluor 488 or Alexa Fluor 546 (1:100, 
Life Technologies, Thermo Fisher Scientific, Waltham, MA, USA) were used as secondary antibodies. Cells were 
mounted on ProLong Gold with 4′,6′-diamidino-2-phenylindole (DAPI) (Thermo Fisher Scientific, Waltham, 
MA, USA) and imaged using a Delta-Vision II microscope system with an Olympus IX-71 inverted microscope 
using a 100 × objective A. Image processing, analysis and display were preformed using DeltaVision softWoRx 
software version 7.0.0 (GE Healthcare Life Sciences) and Adobe Photoshop 21.2.0 (https ://www.adobe .com/
produ cts/photo shop.html). Adjustments to brightness and contrast were made for display purposes.
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Data availability
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